DEERFIELD MANAGEMENT COMPANY, L.P. Q4 2021 Filing
Filed February 14, 2022
Portfolio Value
$4.8B
Holdings
126
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (126 positions)
| Stock | Value |
|---|---|
NUVLNUVALENT INC | $368.3M |
VTRSVIATRIS INC | $281.1M |
AHCOADAPTHEALTH CORP | $250.1M |
GKOS 2.75 06/15/27GLAUKOS CORP | $242.4M |
—INVITAE CORP | $153.3M |
—AERIE PHARMACEUTICALS INC | $130.2M |
—CAREMAX INC | $128.9M |
NBIXNEUROCRINE BIOSCIENCES INC | $117.4M |
NVST 2.375 06/01/25ENVISTA HOLDINGS CORPORATION | $116.5M |
NTRA 2.25 05/01/27NATERA INC | $115.8M |
—SINGULAR GENOMICS SYSTEMS IN | $105.3M |
GMED 1 06/01/23NUVASIVE INC | $96.6M |
PCRX 0.75 08/01/25PACIRA BIOSCIENCES INC | $90.5M |
CNCCENTENE CORP DEL | $82.7M |
—TABULA RASA HEALTHCARE INC | $80.5M |
OPHTEURIVERIC BIO INC | $79.6M |
ORGOORGANOGENESIS HLDGS INC | $78.1M |
PODD 0.375 09/01/26INSULET CORP | $76.4M |
LUNGPULMONX CORP | $75.9M |
GMED 0.375 03/15/25NUVASIVE INC | $74.7M |
NVRO 2.75 04/01/25NEVRO CORP | $68.2M |
SILKSILK RD MED INC | $64.6M |
LRMRLARIMAR THERAPEUTICS INC | $62.9M |
SMFRUSDSEMA4 HOLDINGS CORP | $62.3M |
EWTXEDGEWISE THERAPEUTICS INC | $60.1M |
BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | $58.9M |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $54.5M |
—INTERCEPT PHARMACEUTICALS IN | $54.4M |
—APRIA INC | $54.0M |
GKOSGLAUKOS CORP | $53.6M |
MIRMMIRUM PHARMACEUTICALS INC | $52.4M |
INSM 1.75 01/15/25INSMED INC | $51.3M |
KURAKURA ONCOLOGY INC | $49.2M |
APLS 3.5 09/15/26APELLIS PHARMACEUTICALS INC | $43.5M |
MOHMOLINA HEALTHCARE INC | $42.9M |
ATECALPHATEC HLDGS INC | $41.1M |
PTGXPROTAGONIST THERAPEUTICS INC | $40.1M |
DAWNDAY ONE BIOPHARMACEUTICALS I | $37.1M |
CYTKCYTOKINETICS INC | $36.9M |
PCRXPACIRA BIOSCIENCES INC | $35.9M |
NVAX 3.75 02/01/23NOVAVAX INC | $34.4M |
XLOXILIO THERAPEUTICS INC | $33.7M |
AERIEURAERIE PHARMACEUTICALS INC | $33.0M |
TOITHE ONCOLOGY INSTITUTE INC | $32.1M |
NUVBNUVATION BIO INC | $30.4M |
SWTXSPRINGWORKS THERAPEUTICS INC | $28.0M |
ESPRESPERION THERAPEUTICS INC NE | $25.0M |
BCRXBIOCRYST PHARMACEUTICALS INC | $23.4M |
MR4MERIDIAN BIOSCIENCE INC | $23.0M |
FIGSFIGS INC | $22.9M |
PHVSPHARVARIS N V | $22.8M |
RVMDREVOLUTION MEDICINES INC | $22.4M |
B7SBROOKDALE SR LIVING INC | $22.1M |
ALECALECTOR INC | $21.8M |
HCAT 2.5 04/15/25HEALTH CATALYST INC | $21.8M |
XERS 5 07/15/25XERIS BIOPHARMA HOLDINGS INC | $21.6M |
BLUBELLUS HEALTH INC NEW | $19.7M |
PRNPROFOUND MED CORP | $19.2M |
RYTMRHYTHM PHARMACEUTICALS INC | $18.6M |
OMGBPOUTSET MED INC | $18.5M |
NVROEURNEVRO CORP | $17.5M |
—KINNATE BIOPHARMA INC | $17.5M |
BBIOBRIDGEBIO PHARMA INC | $16.7M |
—ONCORUS INC | $16.6M |
TERNTERNS PHARMACEUTICALS INC | $16.6M |
APLSAPELLIS PHARMACEUTICALS INC | $16.2M |
INZYINOZYME PHARMA INC | $16.0M |
—DA32 LIFE SCNCE TEC ACQSTN C | $15.7M |
KALVKALVISTA PHARMACEUTICALS INC | $15.5M |
—PTC THERAPEUTICS INC | $15.3M |
—APOLLO ENDOSURGERY INC | $14.8M |
—VINCERX PHARMA INC | $14.1M |
MRUSMERUS N V | $13.9M |
COGTCOGENT BIOSCIENCES INC | $13.7M |
MRTXEURMIRATI THERAPEUTICS INC | $12.9M |
SRPTSAREPTA THERAPEUTICS INC | $12.7M |
PMVPPMV PHARMACEUTICALS INC | $12.1M |
2L9BLUEPRINT MEDICINES CORP | $11.8M |
HOWLWEREWOLF THERAPEUTICS INC | $11.4M |
QSIQUANTUM SI INC | $11.0M |
LIANYLIANBIO | $11.0M |
NYXHNYXOAH S A | $10.5M |
CGEMCULLINAN ONCOLOGY INC | $10.4M |
TLSIMEDTECH ACQUISITION CORP | $9.9M |
—SARISSA CAPITAL ACQUISITN CO | $9.8M |
—EUCRATES BIOMEDICAL ACQU COR | $9.8M |
—REVOLUTION HEALTHCAR AQ CORP | $9.7M |
—SENIOR CONNECT ACQUISITN COR | $9.7M |
—GRAYBUG VISION INC | $9.7M |
ORTXUSDORCHARD THERAPEUTICS PLC | $9.2M |
AFIBACUTUS MED INC | $9.0M |
WEAVWEAVE COMMUNICATIONS INC | $8.4M |
GH 0 11/15/27GUARDANT HEALTH INC | $8.1M |
PRVAPRIVIA HEALTH GROUP INC | $7.8M |
—TURMERIC ACQUISITION CORP | $7.4M |
HYPRHYPERFINE INC | $7.3M |
—IGNYTE ACQUISITION CORP | $7.1M |
DHDEFINITIVE HEALTHCARE CORP | $6.8M |
ANNXANNEXON INC | $6.7M |
BNFT 1.25 12/15/23BENEFITFOCUS INC | $6.2M |
Page 1 of 2Next